Search Results - "van Velsen, Evert F S"

Refine Results
  1. 1
  2. 2

    Assessment of Radiofrequency Ablation for Papillary Microcarcinoma of the Thyroid: A Systematic Review and Meta-analysis by van Dijk, Sam P J, Coerts, Hannelore I, Gunput, Sabrina T G, van Velsen, Evert F S, Medici, Marco, Moelker, Adriaan, Peeters, Robin P, Verhoef, Cornelis, van Ginhoven, Tessa M

    Published in JAMA otolaryngology-- head & neck surgery (01-04-2022)
    “…Papillary microcarcinomas of the thyroid (mPTCs) account for an increasing proportion of thyroid cancers in past decades. The use of radiofrequency ablation…”
    Get more information
    Journal Article
  3. 3

    Evaluating Disease-specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer by van Velsen, Evert F S, Peeters, Robin P, Stegenga, Merel T, van Kemenade, Folkert J, van Ginhoven, Tessa M, van Balkum, Mathé, Verburg, Frederik A, Visser, W Edward

    “…Abstract Background Many countries have national guidelines for the management of differentiated thyroid cancer (DTC), including a risk stratification system…”
    Get full text
    Journal Article
  4. 4

    Evaluation of the 2015 ATA Guidelines in Patients With Distant Metastatic Differentiated Thyroid Cancer by van Velsen, Evert F S, Stegenga, Merel T, van Kemenade, Folkert J, Kam, Boen L R, van Ginhoven, Tessa M, Visser, W Edward, Peeters, Robin P

    “…Abstract Context Current American Thyroid Association (ATA) Management Guidelines for the treatment of differentiated thyroid cancer (DTC) stratify patients to…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer by van Velsen, Evert F S, Visser, W Edward, Stegenga, Merel T, Mäder, Uwe, Reiners, Christoph, van Kemenade, Folkert J, van Ginhoven, Tessa M, Verburg, Frederik A, Peeters, Robin P

    Published in Thyroid (New York, N.Y.) (01-07-2021)
    “…Differentiated thyroid cancer (DTC) is the only cancer entity for which the UICC/AJCC (Union for International Cancer Control and American Joint Committee on…”
    Get more information
    Journal Article
  8. 8

    Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification by Stegenga, Merel T, Oudijk, Lindsey, van Velsen, Evert F S, Peeters, Robin P, Medici, Marco, Verburg, Frederik A, van Ginhoven, Tessa M, van Kemenade, Folkert J, Visser, W Edward

    “…The 2022 WHO Classification categorizes oncocytic (OTC) and follicular thyroid carcinoma (FTC) based on the degree of capsular and vascular invasion into…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Longitudinal analysis of quality of life in patients treated for differentiated thyroid cancer by van Velsen, Evert F S, Massolt, Elske T, Heersema, Hélène, Kam, Boen L R, van Ginhoven, Tessa M, Visser, W Edward, Peeters, Robin P

    Published in European journal of endocrinology (01-12-2019)
    “…Objective Earlier cross-sectional studies showed that patients with differentiated thyroid cancer (DTC) have a significant reduction of quality of life (QoL)…”
    Get full text
    Journal Article
  12. 12

    Tumor size and presence of metastases in differentiated thyroid cancer: comparing cohorts from two countries by van Velsen, Evert F S, Peeters, Robin P, Stegenga, Merel T, Mäder, Uwe, Reiners, Christoph, van Kemenade, Folkert J, van Ginhoven, Tessa M, Visser, W Edward, Verburg, Frederik A

    Published in European journal of endocrinology (07-06-2023)
    “…Incidence of thyroid cancer varies widely, even across neighboring countries. Data on this phenomenon are largely lacking but are likely related to differences…”
    Get full text
    Journal Article
  13. 13

    Serum alkaline phosphatase can be elevated in patients with hypophosphatasia due to liver disease by van Velsen, Evert F.S., Zervou, Zografia, Zillikens, M. Carola

    Published in European journal of medical genetics (01-11-2023)
    “…Hypophosphatasia (HPP) is a rare inherited disorder caused by pathogenic loss-of-function variants in the ALPL gene, encoding the tissue-nonspecific isoenzym…”
    Get full text
    Journal Article
  14. 14

    The influence of age on disease outcome in 2015 ATA high-risk differentiated thyroid cancer patients by van Velsen, Evert F S, Peeters, Robin P, Stegenga, Merel T, van Kemenade, Folkert J, van Ginhoven, Tessa M, Verburg, Frederik A, Visser, W Edward

    Published in European journal of endocrinology (01-09-2021)
    “…Objective Recent research suggests that the addition of age improves the 2015 American Thyroid Association (ATA) Risk Stratification System for differentiated…”
    Get full text
    Journal Article
  15. 15

    Diagnostic and Treatment Considerations for Thyroid Cancer in Women of Reproductive Age and the Perinatal Period by van Velsen, Evert F.S., Leung, Angela M., Korevaar, Tim I.M.

    “…Thyroid cancer is one of the most common cancers diagnosed in women of reproductive age and during pregnancy. This leads to important questions about thyroid…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Impressive clinical improvement and disappearance of neuropathic pain in an adult patient with hypophosphatasia treated with asfotase alfa by Zervou, Zografia, Plooij, Roel, van Velsen, Evert F.S., Timmermans, Remco G.M., Demirdas, Serwet, Zillikens, M. Carola

    Published in European journal of medical genetics (01-04-2024)
    “…Hypophosphatasia (HPP) is a rare disorder, resulting from loss-of-function variants of the ALPL gene encoding non-tissue specific alkaline phosphatase…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20